Midday movers: Nvidia, Dell rise; Live Nation, Boeing fall

Go back to Midday movers: Nvidia, Dell rise; Live Nation, Boeing fall

Netlist (NLST) awarded $445m in patent infringement trial against Micron (MU)

May 24, 2024 8:54 AM EDT

Netlist (OTC: NLST) has secured a $445 million damages award in a patent infringement case against Micron Technology (NASDAQ: MU), including its subsidiaries Micron Semiconductor Products and Micron Technology Texas LLC.

The verdict, delivered by a... More

RBC Capital Reiterates Sector Perform Rating on Medtronic, Inc. (MDT)

May 24, 2024 6:16 AM EDT

RBC Capital analyst Shagun Singh reiterated a Sector Perform rating and $92.00 price target on Medtronic, Inc. (NYSE: MDT).

The analyst comments "MDT delivered a beat (upside surprise of 1.7%/0.7% on sales/EPS, respectively), but FY25 guidance was in-line and FQ1 modestly below, sending... More

Seaport Global Securities Reiterates Buy Rating on Live Nation Entertainment (LYV)

May 24, 2024 6:10 AM EDT

Seaport Global Securities analyst David Joyce reiterated a Buy rating and $115.00 price target on Live Nation Entertainment (NYSE: LYV).

The analyst comments "The Department of Justice finally filed its antitrust lawsuit against Live Nation Entertainment (and thereby going counter to its 2010 approval of their merger - could that open... More

Medtronic, Inc. (MDT) PT Raised to $105 at Wells Fargo

May 24, 2024 5:20 AM EDT

Wells Fargo analyst Larry Biegelsen raised the price target on Medtronic, Inc. (NYSE: MDT) to $105.00 (from $102.00) while maintaining a Overweight rating.

The analyst comments "Strong FQ4 rev beat, but elevated opex drives muted EPS beat. MDT reported FQ4 2024 rev of $8.59B (+5.4% organic)... More

Medtronic, Inc. (MDT) PT Raised to $76 at UBS

May 24, 2024 4:59 AM EDT

UBS analyst Danielle Antalffy raised the price target on Medtronic, Inc. (NYSE: MDT) to $76.00 (from $75.00) while maintaining a Sell rating.

The analyst comments "Despite Outperformance, We Remain Skeptical of Sustainability of New Product Momentum; Commentary Suggests FY25 Consensus EPS Possibly... More

Stifel Reiterates Buy Rating on Medtronic, Inc. (MDT)

May 23, 2024 4:25 PM EDT

Stifel analyst Rick Wise reiterated a Buy rating and $100.00 price target on Medtronic, Inc. (NYSE: MDT).

The analyst comments "Notching a sixth consecutive mid-single-digit top-line revenue growth quarter (+5.4% organic), Medtronics 18 months of more-consistent performance positively suggest stable underlying business fundamentals. Now starting FY2025... More

BTIG Reiterates Neutral Rating on Medtronic, Inc. (MDT)

May 23, 2024 4:15 PM EDT

BTIG analyst Sean Lavin reiterated a Neutral rating on Medtronic, Inc. (NYSE: MDT).

The analyst comments "We maintain our Neutral rating following FY4Q24 results. MDT reported rev. of $8.589B (0.5% Y/Y, 5.4% organic) and adj. EPS of $1.46 (-7% Y/Y), above BTIG/Consensus ests. of $8.443B/$8.445B and adj. EPS of $1.46/$1.45 by ~1.7% and ~0.6% respectively. Segment performance was favorable in Neuroscience (3.6% vs. Cons), Medical-Surgical (1.1% vs. Cons), and Diabetes (+0.9% vs. Cons)... More

Citi Reiterates Buy Rating on Live Nation Entertainment (LYV)

May 23, 2024 4:06 PM EDT

Citi analyst Jason Bazinet reiterated a Buy rating and $130.00 price target on Live Nation Entertainment (NYSE: LYV)

The analyst comments "Earlier today, the DOJ and a group State Attorneys General filed an antitrust lawsuit against Live Nation. We learned three interesting things... More

Boeing (BA) PT Lowered to $230 at Stifel

May 23, 2024 3:34 PM EDT

Stifel analyst Bert Subin lowered the price target on Boeing (NYSE: BA) to $230.00 (from $240.00) while maintaining a Buy rating.

The analyst comments "This morning, CFO Brian West made comments at an investor conference, suggesting lower-than-expected FCF in 2Q, circa the ~($4B)... More

Boeing (BA) PT Lowered to $147 at CFRA

May 23, 2024 2:31 PM EDT

CFRA analyst Stewart Glickman lowered the price target on Boeing (NYSE: BA) to $147.00 (from $151.00) while maintaining a Sell rating.

The analyst comments "Our 12-month target price of $147, cut $4, reflects a 26x multiple of projected 2025 EPS, in line with BA's long-term historical forward... More

BMO Capital Upgrades DuPont (DD) to Outperform

May 23, 2024 2:30 PM EDT

BMO Capital analyst John McNulty upgraded DuPont (NYSE: DD) from Market Perform to Outperform with a price target of $96.00 (from $83.00).

The analyst comments "In what may be the last step of his multi-phase journey, Ed Breen/DD announced plans to separate into three companies (in... More

Wolfe Research Releases Key Talking Points from Conference with Boeing (BA)

May 23, 2024 12:07 PM EDT

Wolfe Research analyst Myles Walton reiterated an Outperform rating and $220.00 price target on Boeing (NYSE: BA).

The analyst comments "We hosted Boeing CFO, Brian West, for a fireside chat at the 17th Annual Wolfe Research Global Transportation and Industrial Conference this morning. Below are the main highlights: 2024 free cash flow is... More